JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban

• Publication date

  2016-02-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11596-016-1547-1PMID 26838746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord

  2014cited by this paper
• &bgr;2‐ and &bgr;3‐adrenergic receptors drive COMT‐dependent pain by increasing production of nitric oxide and cytokines

  2014cited by this paper
• NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice

  2014cited by this paper
• The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

  2014cited by this paper
• TNF-α induces CXCL1 chemokine expression and release in human vascular endothelial cells in vitro via two distinct signaling pathways

  2014cited by this paper
• [Bone cancer pain: from preclinical pharmacology to clinical trials].

  2013cited by this paper
• Animal models of bone cancer pain: Systematic review and meta‐analyses

  2013cited by this paper
• Chemokine contribution to neuropathic pain: Respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons

  2013cited by this paper
• Bone cancer pain: Causes, consequences, and therapeutic opportunities

  2013cited by this paper
• Dolor oncológico óseo: de la farmacología preclínica a los ensayos clínicos

  2013cited by this paper
• Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats

  2012cited by this paper
• Increased function of the TRPV1 channel in small sensory neurons after local inflammation or in vitro exposure to the pro-inflammatory cytokine GRO/KC

  2012cited by this paper
• The c‐Jun N‐terminal kinase 1 (JNK1) in spinal astrocytes is required for the maintenance of bilateral mechanical allodynia under a persistent inflammatory pain condition

  2010cited by this paper
• Limited BDNF contributes to the failure of injury to skin afferents to produce a neuropathic pain condition

  2010cited by this paper
• NF-κB mediated enhancement of potassium currents by the chemokine CXCL1/growth related oncogene in small diameter rat sensory neurons

  2009cited by this paper
• Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model.

  2009cited by this paper
• JNK-Induced MCP-1 Production in Spinal Cord Astrocytes Contributes to Central Sensitization and Neuropathic Pain

  2009cited by this paper
• Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation.

  2008cited by this paper
• Activation of JNK pathway in persistent pain.

  2008cited by this paper
• The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons

  2008cited by this paper
• Pharmacological isolation of postsynaptic currents mediated by NR2A- and NR2B-containing NMDA receptors in the anterior cingulate cortex

  2007cited by this paper
• Tumor necrosis factor-α induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: The role of NF-kappa B, JNK and p38 MAPK

  2007cited by this paper
• Chemokines and the pathophysiology of neuropathic pain

  2007cited by this paper
• Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain

  2007cited by this paper
• A Peptide c-Jun N-Terminal Kinase (JNK) Inhibitor Blocks Mechanical Allodynia after Spinal Nerve Ligation: Respective Roles of JNK Activation in Primary Sensory Neurons and Spinal Astrocytes for Neuropathic Pain Development and Maintenance

  2006cited by this paper
• Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival.

  2006cited by this paper
• A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells.

  2006cited by this paper
• Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases

  2006cited by this paper
• CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis.

  2005cited by this paper
• CCL2 and CXCL1 trigger calcitonin gene‐related peptide release by exciting primary nociceptive neurons

  2005cited by this paper
• GRO-α and CXCR2 in the Human Fetal Brain and Multiple Sclerosis Lesions

  2003cited by this paper
• Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion.

  2003cited by this paper
• GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions.

  2003cited by this paper
• A rat model of bone cancer pain

  2002cited by this paper
• Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells.

  2001cited by this paper
• Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury

  1998cited by this paper
• Expression of chemokine receptors by subsets of neurons in the central nervous system.

  1997cited by this paper
• A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

  1987cited by this paper

• Long noncoding RNA NONRATT007487.2 drives cancer-induced bone pain progression through direct interaction with CXCL1

  2025cites this paper
• Molecular targets in bone cancer pain: a systematic review of inflammatory cytokines

  2024cites this paper
• Inhibiting the JNK Signaling Pathway Attenuates Hypersensitivity and Anxiety-Like Behavior in a Rat Model of Non-specific Chronic Low Back Pain

  2024cites this paper
• Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases.

  2019cites this paper
• The importance of chemokines in neuropathic pain development and opioid analgesic potency

  2018cites this paper
• Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine

  2018cites this paper
• Levo‐corydalmine alleviates vincristine‐induced neuropathic pain in mice by inhibiting an NF‐kappa B‐dependent CXCL1/CXCR2 signaling pathway

  2018cites this paper
• Anti-nociceptive Role of CXCL1 in a Murine Model of Peripheral Nerve Injury-induced Neuropathic Pain.

  2018cites this paper
• The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats

  2016cites this paper